|
Volumn 901, Issue 1-2, 2001, Pages 62-70
|
Effect of long-term administration of JTP-2942, a novel thyrotropin-releasing hormone analogue, on neurological outcome, local cerebral blood flow and glucose utilization in a rat focal cerebral ischemia
a a a a a a a a |
Author keywords
Focal cerebral ischemia; Local cerebral blood flow (1 CBF); Local cerebral glucose utilization (1 CGU); Neurological examination; Thyrotropin releasing hormone (TRH)
|
Indexed keywords
JTP 2942;
NALPHA (2 METHYL 4 OXOCYCLOPENTYLCARBONYL)HISTIDYLPROLINAMIDE;
PROTIRELIN DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ARTICLE;
BRAIN BLOOD FLOW;
BRAIN INFARCTION;
BRAIN ISCHEMIA;
BRAIN METABOLISM;
CONTROLLED STUDY;
DRUG STRUCTURE;
FRONTAL CORTEX;
GLUCOSE METABOLISM;
MALE;
MIDDLE CEREBRAL ARTERY OCCLUSION;
MOTOR CORTEX;
MOTOR DYSFUNCTION;
NEUROLOGIC DISEASE;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
REPERFUSION;
SYNAPSE;
ANIMALS;
BRAIN;
BRAIN INFARCTION;
BRAIN ISCHEMIA;
CARDIOVASCULAR PHYSIOLOGY;
CEREBROVASCULAR CIRCULATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
GLUCOSE;
MALE;
MOVEMENT DISORDERS;
NEURONS;
RATS;
RATS, WISTAR;
REPERFUSION INJURY;
RESPIRATORY PHYSIOLOGY;
THYROTROPIN-RELEASING HORMONE;
|
EID: 0035906515
PISSN: 00068993
EISSN: None
Source Type: Journal
DOI: 10.1016/S0006-8993(01)02260-0 Document Type: Article |
Times cited : (4)
|
References (36)
|